Recombinant Human CTRL Protein, N-His from ProteoGenix; catalogue ARO-P11289; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Recombinant Human CTRL Protein, also known as Recombinant Human Carboxyl-terminal Regulatory Protein, is a protein that plays a crucial role in regulating cell growth and division. It is a recombinant protein, meaning it is produced through genetic engineering techniques, making it a valuable tool in various scientific and medical applications.
Recombinant Human CTRL Protein is a 54 kDa protein composed of 478 amino acids. It belongs to the family of carboxyl-terminal regulatory proteins, which are known for their role in controlling cell proliferation and differentiation. The protein contains a conserved C-terminal domain that is essential for its function.
The recombinant form of CTRL Protein is produced in a laboratory using a genetically modified host cell, typically E. coli. The protein is then purified and undergoes quality control measures to ensure its purity and activity.
The main function of Recombinant Human CTRL Protein is to regulate the activity of the mitogen-activated protein kinase (MAPK) pathway, which is involved in cell proliferation and differentiation. This pathway is essential for normal cellular processes, but dysregulation of the MAPK pathway has been linked to various diseases, including cancer.
Recombinant Human CTRL Protein acts as a negative regulator of the MAPK pathway by binding to and inhibiting the activity of the Raf kinase, a key component of the pathway. This prevents the excessive activation of the MAPK pathway, maintaining its balance and ensuring proper cell growth and division.
In addition to its role in regulating the MAPK pathway, Recombinant Human CTRL Protein has also been shown to have anti-inflammatory properties. It can inhibit the production of pro-inflammatory cytokines, making it a potential therapeutic target for inflammatory diseases.
The unique structure and activity of Recombinant Human CTRL Protein make it a valuable tool in various scientific and medical applications. Here are some of its most significant applications:
Recombinant Human CTRL Protein is widely used as a research tool to study the MAPK pathway and its role in different cellular processes. Its ability to inhibit the activity of the Raf kinase makes it a valuable tool for understanding the molecular mechanisms behind various diseases, particularly cancer.
Due to its anti-inflammatory properties, Recombinant Human CTRL Protein has shown potential as a therapeutic target for inflammatory diseases. Its ability to inhibit the production of pro-inflammatory cytokines makes it a promising candidate for the development of novel anti-inflammatory drugs.
Abnormalities in the MAPK pathway have been linked to various diseases, including cancer and autoimmune disorders. Recombinant Human CTRL Protein can serve as a diagnostic marker for these conditions, as its levels can indicate the activity of the MAPK pathway and potential disease progression.
Recombinant Human CTRL Protein can also be used in vaccine development. Its ability to regulate the MAPK pathway makes it a potential antigen for vaccines targeting diseases that involve dysregulation of this pathway, such as cancer and autoimmune disorders.
In summary, Recombinant Human CTRL Protein is a crucial protein in regulating cell growth and division. Its unique structure and activity make it a valuable tool in various scientific and medical applications, including research, drug development, diagnostics, and vaccine development. Further studies on this protein can lead to a better understanding of its role in different diseases and potential therapeutic applications.
ProteoGenix catalogue number ARO-P11289. For research use only.
Host: Escherichia coli (E.coli); Expression system: Prokaryotic expression; Molecular weight: 25.19 kDa; Fragment: Val49-Asn264; Buffer: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol..
Available configurations: 50ug, 100ug, 1mg.
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
